Hantz Financial Services Inc. Raises Stake in Roche Holding AG (OTCMKTS:RHHBY)

Hantz Financial Services Inc. boosted its stake in Roche Holding AG (OTCMKTS:RHHBY) by 0.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 33,708 shares of the company’s stock after acquiring an additional 305 shares during the period. Hantz Financial Services Inc.’s holdings in Roche were worth $1,176,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Brooklyn Investment Group lifted its position in shares of Roche by 36.6% during the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock valued at $48,000 after buying an additional 363 shares during the last quarter. Diversified Trust Co lifted its holdings in Roche by 1.2% during the fourth quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock valued at $2,130,000 after purchasing an additional 711 shares during the last quarter. Bard Financial Services Inc. boosted its position in Roche by 37.7% during the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock worth $3,866,000 after purchasing an additional 30,350 shares during the period. Confluence Investment Management LLC increased its stake in shares of Roche by 26.3% in the fourth quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock worth $488,000 after purchasing an additional 2,910 shares in the last quarter. Finally, IHT Wealth Management LLC purchased a new stake in shares of Roche during the 3rd quarter valued at approximately $236,000.

Roche Stock Down 1.5 %

Roche stock opened at $39.25 on Friday. The firm has a 50 day simple moving average of $36.14 and a 200 day simple moving average of $38.25. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86. Roche Holding AG has a 1-year low of $29.20 and a 1-year high of $42.43.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.